2026/02/11 by Ana Beathriz Leite [UNESP] Lorente, Sergio Vazquez, Kanako Iwasaki +7 · 1 voice
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Congenital heart defects research #Pancreatic function and diabetes #Phagocytosis and Immune Regulation
paper · pdf · doi:10.18632/aging.206398
openalex publication_date 2026/02/11 · openalex created_date 2026/07/09 · openalex updated_date 2026/07/12
Senescent pancreatic beta (β)-cells accumulate with age and contribute to impaired insulin secretion and progression of type 2 diabetes mellitus (T2DM).Although the urokinase-type plasminogen activator receptor (uPAR; encoded by PLAUR) has been used as a surface marker of senescence in mice and humans, its broad expression across tissues limits therapeutic specificity.Here, we identify transmembrane-4-L-six-family member-1 (TM4SF1) as a selective surface marker of senescent β-cells.Using RNA sequencing, flow cytometry, and immunofluorescence, we demonstrate that TM4SF1 is enriched in p21 (encoded by CDKN1A) senescent β-cells, with minimal expression in non-senescent β-cells or nonpancreatic cell types.TM4SF1 + β-cells exhibit reduced insulin content and impaired glucose-stimulated insulin secretion, linking this population to functional decline.Importantly, compared to uPAR, TM4SF1 shows stronger concordance with canonical senescence markers and greater specificity for β-cells.These findings establish TM4SF1 as a robust and selective marker of senescent βcells and support its potential as a target for β-cell-directed senotherapeutic strategies in T2DM.